Inflammatory Bowel Disease
result of long-term adaptation, J Gastrointest Surg, 2003;7:246–53, discussion 253–4.
6. Ettorre GM, Pescatori M, Panis Y, et al., Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn’s colitis, Dis Colon Rectum, 2000;43:1743–8.
7. Kock NG, Darle N, Hultén L, et al., Ileostomy, Curr Probl Surg, 1977;14:36–8.
8. Shen B, Shermock KM, Fazio VW, et al., Clinical approach to diseases of ileal pouch-anal anastomosis, Am J Gastroenterol, 2005;100:2796–807.
9. Coffey JC, Calvin J, McCarthy E, et al., Pouchitis: an evolving clinical enigma – a review, Dis Colon Rectum, 2009;52:140–53.
10. Maser EA, Present DH, Pouch-ouch, Curr Opin Gastroenterol, 2008;24:70–4.
11. Balbir-Gurman A, Schapira D, Nahir M, Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis, Semin Arthritis Rheum, 2001;30:242–8.
12. Nakamura M, Ikeuchi H, Nakano H, et al., Postoperative joint symptoms: a risk factor for pouchitis in ulcerative colitis patients, Dig Surg, 2006;23:60–4.
13. Freeman HJ, Pouchitis-associated iritis (uveitis) following total proctocolectomy and ileal pouch-to-anal anastomosis in ulcerative colitis, Can J Gastroenterol, 2001;15:131–3.
14. Abdelrazeq AS, Lund JN, Leveson SH, Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis, Eur J Gastroenterol Hepatol, 2004;16:1057–8.
15. Pastrana RJ, Torres EA, Arroyo JM, et al., Iron-deficiency anemia as presentation of pouchitis, J Clin Gastroenterol, 2007;41:41–4.
16. Johnson MW, Maestranzi S, Duffy A, et al., Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis, Eur J Gastroenterol Hepatol, 2008;20:174–9.
17. Lim M, Gonsalves S, Thekkinkattil D, et al., The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch, Dis Colon Rectum, 2008;51:96–9.
18. Walkowiak J, Banasiewicz T, Krokowicz P, et al., Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis, Scand J Gastroenterol, 2005;40:1493–4.
19. Pardi DS, Shen B, Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis, Endoscopy, 2008;40:529–33.
20. Calabrese C, Fabbri A, Gionchetti P, et al., Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis, Aliment Pharmacol Ther, 2007;25:1311–6.
21. Moskowitz RL, Shepard NA, Nicholls JR, An assessment of inflammation in the reservoir after restorative proctocolectomy with ileo-anal ileal reservoir, Int J Colorectal Dis, 1986;1:67–74.
22. Shepard NA, Jass JR, Duval I, et al., Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens, J Clin Pathol, 1987;40:601–7.
23. Hirata N, Oshitani N, Kamata N, et al., Proliferation of immature plasma cells in pouchitis mucosa in patients with ulcerative colitis, Inflamm Bowel Dis, 2008;14: 1084–90.
24. Setti Carrato P, Talbot IC, Nicholls RJ, Long term appraisal of the histological appearance of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis, Gut, 1994;35:1717–21.
25. Kariv R, Plesic TP, Gaffney K, et al., Pyloric gland metaplasia and pouchitis in patients with ileal pouch-anal anastomosis, Aliment Pharmacol Ther, 2010;31:862–73.
26. Crema MD, Richarme D, Azizi L, et al., Pouchography, CT, MRI features of ileal J pouch-anal anastomosis, Am J Roentgenol, 2006;187:W594–603.
27. Nadgir RN, Soto JA, K. Dendrinos K, et al., MRI of complicated pouchitis, Am J Roentgenol, 2006;187:W386–91.
28. Navaneethan U, Shen B, Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors, Am J Gastroenterol, 2010;105:51–64.
29. Heuschen UA, Hinz U, Allemeyer EH, et al., Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis, Dis Colon Rectum, 2001;44:487–99.
30. Rauh SM, Schoetz DJ Jr, Roberts PL, et al., Pouchitis – is it a wastebasket diagnosis?, Dis Colon Rectum, 1991;34:685–9.
31. Shen B, Lashner BA, Pouchitis: a spectrum of diseases, Curr Gastroenterol Rep, 2005;7:404–11.
32. Thompson-Fawcett MW, Mortensen NJ, Warren BF, “Cuffitis” and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis, Dis Colon Rectum, 1999;42:348–55.
33. Shen B, Achkar J-P, Lashner BA, et al., Irritable pouch syndrome: a new category or diagnosis for symptomatic patients with ileal pouch-anal anastomosis, Am J Gastroenterol, 2002;97:972–7.
34. Schmidt C, Häuser W, Giese T, et al., Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts, Inflamm Bowel Dis, 2007;13:1502–8.
35. Mann SD, Pitt J, Springall RG, Thillainayagam AV, Clostridium
Difficile infection – an unusual cause of refractory pouchitis: report of a case, Dis Colon Rectum, 2003;46:267–70.
36. Shen B, Goldblum JR, Hull TL, et al., Clostridium Difficile-associated pouchitis, Digestive Dis Sci, 2006;51:2361–4.
37. Pfau PR, Lichtenstein GR, Cytomegalovirus infection as a cause of ileoanal pouchitis, Dis Colon Rectum, 2000;43:113–4.
38. Shen B, Campylobacter infection in patients with ileal pouches, Am J Gastroenterol, 2010;105:472–3.
39. Shen B, Plesec TP, Remer E, et al., Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis?, Inflamm Bowel Dis, 2010;16:836–46.
40. Kienle P, Weitz J, Reinshagen S, et al., Association of decreased perfusion of the ileoanal pouch mucosa with early postoperative pouchitis and local septic complications, Arch Surg, 2001;136:1124–30.
41. Sandborn WJ, Tremaine WJ, Batts KP, Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index, Mayo Clin Proc, 1994;69:409–15.
42. Shen B, Achkar J-P, Lashner BA, et al., Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis, Gastroenterology, 2001;121:261–7.
43. Beart RW Jr., Is pouchitis a clinical, endoscopic, or histologic problem?, Dis Colon Rectum, 2004;47:949; author reply 949–50.
44. Shen B, Shermock KM, Fazio VW, et al., A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis, Am J Gastroenterol, 2003;98:2460–7.
45. Stahlberg D, Gullberg K, Liljeqvist L, et al., Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk and risk factors, Dis Colon Rectum, 1996;39:1012–8.
46. Penna C, Dozois R, Tremaine W, et al., Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis, Gut, 1996;38:234–9.
47. Simchuk EJ, Thirlby RC, Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomosis, World J Surg, 2000;24:851–6.
48. Svaninger G, Nordgren S, Oresland T, Hultén L, Incidence and characteristics of pouchitis in the Kock continent ileostomy and pelvic pouch, Scand J Gastroenterol, 1993;28:695–700.
49. McLaughlin SD, Clark SK ,Tekkis PP, et al., Dysbiosis and pouchitis, (Br J Surg, 2006;93:1325–34), Br J Surg, 2007;94:383–4, author reply 384.
50. Ohge H, Furne J, Springfield J, et al., Association between fecal hydrogen sulfide production and pouchitis, Dis Colon Rectum, 2005;48:469–75.
51. Shebani KO, Stucchi AF, McClung JP, et al., Role of stasis and oxidative stress in ileal pouch inflammation, J Surg Res, 2000;90:67–75.
52. Komanduri S, Gillevet PM, Sikaroodi M, et al., Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation, Clin Gastroenterol Hepatol, 2007;5:352–60.
53. Lim M, Adams JD, Wilcox M, et al., An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota, Dis Colon Rectum, 2009;52:1492–500.
54. Lim M, Sagar P, Finan P, et al., Dysbiosis and pouchitis, Br J Surg, 2006;93: 1325–34.
55. Tytgat GNJ, van Deventer SJH, Pouchitis, Int J Colorect Dis, 1988;3:226–8.
56. De Preter V, Bulteel V, Suenaert P, et al., Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa, Inflamm Bowel Dis, 2009;15:335–40.
57. Clausen MR, Tvede M, Mortensen PB, Short-chain fatty acids in pouch contents from patients with and without pouchitis after ileal pouch anal anastomosis, Gastroenterology, 1992;103:1144–53.
58. Carter MJ, Di Giovine FS, Cox A, et al., The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis, Gastroenterology, 2001;121:805–11.
59. Schmidt C, Giese T, Ludwig B, et al., Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity, Int J Colorectal Dis, 2006;21:419–26.
60. Bulois P, Tremaine WJ, Maunoury V, et al., Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10, Inflammatory Bowel Dis, 2000;6:157–64.
61. Thomas PD, Forbes A, Nicholls RJ, et al., Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis, Scand J Gastroenterol, 2001;36:258–64.
62. Amasheh S, Schmidt T, Mahn M, et al., Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease, Int J Colorectal Dis, 2009;24:1149–56.
63. Kroesen AJ, Stockmann M, Ransco C, et al., Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis, Gut, 2002;50:821–6.
64. Kroesen AJ, Leistenschneider P, Lehmann K, et al., Increased bacterial permeation in long-lasting ileoanal pouches, Inflamm Bowel Dis, 2006;12:736–44.
65. M’Koma AE, Wise PE, Muldoon RL, et al., Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones, Int J Colorectal Dis, 2007;22:1143–63.
66. Dube S, Heyen F, Pouchitis and gastric hyposecretion: cause or effect?, Int J Colorectal Dis, 1990;5:142–3.
67. Sandborn W, Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment, Gastroenterology, 1994;107:1856–60.
68. Gray M, Colwell JC, Pouchitis: Part 1: Etiologies and risk factors, J Wound Ostomy Continence Nurs, 2002;29:68–73.
69. Coffey JC, Rowan F, Burke J, et al., Pathogenesis of and unifying hypothesis for idiopathic pouchitis, Am J Gastroenterol, 2009;104:1013–23.
70. Pardi DS, D’Haens G, Shen B, et al., Clinical guidelines for the management of pouchitis, Inflamm Bowel Dis, 2009;15:1424–31.
71. Sandborn W J, Pouchitis: risk factors, frequency, natural history, classification, and public health prospective. In: Meleod RS, Martin F, Sutherland LR (eds), Trends in Inflammatory Bowel Disease, Lancaster: Kluwer Academic Publishers, 1997:51–63.
72. Madden MV, McIntyre AS, Nicholls RJ, Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis, Dig Dis Sci, 1994;39:1193–6.
73. Shen B, Achkar JP, Lashner BA, et al., A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis, lnflamm Bowel Dis, 2001;7:301–5.
74. Gosselink MP, Schouten WR, van Lieshout LM, et al., Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis, Dis Colon Rectum, 2004;47:1519–25.
75. Mimura T, Rizzello F, Helwig U, et al., Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis, Aliment Pharmacol Ther, 2002;16:909–17.
76. Abdelrazeq AS, Kelly SM, Lund JN, et al., Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis, Colorectal Dis, 2005;7: 182–6.
77. Shen B, Fazio VW, Remzi FH, et al., Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis, Dis Colon Rectum, 2007;50:498–508.
78. Pardi DS, Sandborn WJ, Systematic review: the management of pouchitis, Aliment Pharmacol Ther, 2006;23:1087–96.
79. Tekkis PP, Nicholls RJ, Ileal pouch dysfunction: diagnosis and management, Gastroenterol Clin North Am, 2010;37:669–83.
80. Nygaard K, Bergan T, Bjorneklett A, et al., Topical metronidazole treatment in pouchitis, Scand J Gastroenterol, 1994;29:462–7.
81. Shen B, Remzi F, Lopez A, et al., Rifaximin for maintenance therapy in antibiotic-dependent pouchitis, BMC Gastroenterol, 2008;8:26.
82. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 2000;119:305–9.
83. Mimura T, Rizzello F, Helwig U, et al., Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, 2004; 53:108–14.
84. McLaughlin SD, Johnson MW, Clark SK, et al., VSL #3 for chronic pouchitis; experience in the UK clinical practice, Gastroenterology, 2008;134 (Suppl. 1): A711.
85. Shen B, Brzezinski A, Fazio VW, et al., Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice, Aliment Pharmacol Ther, 2005;22:721–8.
86. Miglioli M, Barbara L, Di Febo G, et al., Topical administration of 5-aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis, N Engl Med, 1989;320:257.
87. Gionchetti P, Rizzello F, Poggioli G, et al., Oral budesonide in the treatment of chronic refractory pouchitis, Aliment Pharmacol Ther, 2007;25:1231–6.
88. Calabrese C, Gionchetti P, Rizzello F, et al., Short-term treatment with infliximab in chronic refractory pouchitis, Aliment Pharmacol Ther, 2008;27:759–64.
89. Viscido A, Habib FI, Kohn A, et al., Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis, Aliment Pharmacol Ther, 2003;17:1263–71.
90. Ferrante M, D’Haens G, Dewit O, et al., Efficacy of infliximab in refractory pouchitis and Crohn’s disease-related complications of the pouch: a Belgian case series, 2010;16:243–9.
91. Shen B, Achkar JP, Connor JT, et al., The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis, Am J Gastroenterol, 2009;104:1468–74.
92. Bell AJ, Re: Adenocarcinoma arising in a background of chronic atrophic pouchitis in an ileoanal pouch for ulcerative colitis, Histopathology, 2009;54:618–9.
93. Knupper N, Straub E, Terpe HJ, et al., Adenocarcinoma of the ileoanal pouch for ulcerative colitis – a complication of severe chronic atrophic pouchitis?, Int J Colorectal Dis, 2006;21:478–82.
94. Naik VS, Patil SB, Scholefield J, et al., Adenocarcinoma arising in a background of chronic atrophic pouchitis in an ileoanal pouch for ulcerative colitis, Histopathology, 2008;53:354–8.
95. Kariv R, Remzi FH, Lian L, et al., Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy, Gastroenterology, 2010;139:806–12.
96. Das P, Johnson MW, Tekkis PP, Nicholls RJ, Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis, Colorectal Dis, 2007;9:15–27.
97. Ault G, Nunoo-Mensah L, Johnson P, et al., Adenocarcinoma arising in the middle of ileoanal pouches: Report of five cases, Dis Colon Rectum, 2009;52: 538–41.
26
US GASTROENTEROLOGY & HEPATOLOGY REVIEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76